Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/25/26 21:56 | 6/25/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | 6 | S.dm | -128,787 | 106.44 | 0 | -1,210 | 675 | I | ||||||||||||||||
6/25/26 18:00 | 6/25/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Goodman Noah | MA | O | Chief Bu | 4 | S.dm | -1,837 | 96.10 | 0 | -19 | 52 | D | |||||||||||||||
5/27/26 17:50 | 5/26/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Chadwick Jeremy G | MA | O | COO | 4 | S.dm | -3,890 | 84.06 | 0 | -46 | 61 | D | |||||||||||||||
5/11/26 16:58 | 5/11/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Ridloff Elena | MA | D | 2 | S.dm | -1,286 | 85.71 | 0 | -15 | -100 | 0 | D | |||||||||||||||
4/29/26 17:00 | 4/29/26 | KYMR | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | 1 | S.d | -2,435 | 81.18 | 0 | -30 | 666 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |